Welcome to SuperLan Chemical Co.,Ltd.
Home > Products > MAPK > p38 MAPK > SB202190

SB202190

(CAS No:152121-30-7)
SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.
CAS No:152121-30-7
Molecular Weight(MW):331.34
Purity:99.00%
Specification:500MG;1G;5G;10G;50G;100G
Price and large packaging, please e-mail consultation:info@SuperLan-chem.com
QC Documents
 COA  MSDS  HPLC  NMR
ChemicalInfomation
CAS No: 152121-30-7
Molecular formula(MF) C20H14N3OF
Molecular Weight(MW): 331.34
Alias 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole
Solubility
In vitro DMSO 66 mg/mL (199.19 mM)
Ethanol 12 mg/mL (36.21 mM)
Water <1 mg/mL
In vivo 1% DMSO+30% polyethylene glycol+1% Tween 80 30 mg/mL
Biological Activity
Description SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.
Targets
p38α [1]
(Cell-free assay)
p38β [1]
(Cell-free assay)
50 nM 100 nM
In vitro

SB 202190 significantly inhibits both basal and anti-Fas antibody-induced MAPKAPK 2 activity in a dose-dependent manner. SB202190 by itself is sufficient to induce cell death in Jurkat and HeLa cells through activation of CPP32-like caspases, which can be blocked by expression of bcl-2. SB202190-induced apoptosis is attenuated by p38β but augmented by p38α. [2] SB 202190 strongly inhibits UVB induced COX-2 protein expression in HaCaT cells, and markedly inhibits UVB induced cox-2 mRNA. [3] SB 202190 treatment inhibits the expression of albumin-induced proinflammatory (monocyte chemoattractant protein-1) and transforming growth factor (TGF)-beta1-induced profibrotic (procollagen-Ialpha1) genes over 50% in renal tubular cells (normal rat kidney-52E). [4] SB 202190 treatment induces phosphorylation of JNK in a dose- and time- dependent manner in A549 cells, induces phosphorylation of ATF-2 transcription factor, and increases AP-1 DNA binding. [6] SB 202190 treatment enhances the growth of THP-1 and MV4-11 cells. SB 202190 increases the phosphorylation of c-Raf and ERK, suggesting that Ras-Raf-MEK-mitogen-activated protein kinase (MAPK) pathway activation is involved in the leukemia cell growth induced by SB 202190. [7]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCT-116 Function Assay 25 μM 30 min DMSO  attenuates the mRNA and protein expression of hBD-2 in responsive to DA 26223251
MDA-MB-231 Function Assay 2 μM 24 h lessenes CCL2 induction by TNFα 26100848
rBMSCs Function Assay 10 μM 2.5 h depresses the phosphorylation of ERK and p38 26053266
MG63 Function Assay 10/20/30 μM 24 h significantly decreases the level of phosphorylated p38 induced by CdCl2 in a concentration -dependent manner 25998312
MG63 Apoptosis Assay 10/20/30 μM 24 h significantly decreased the apoptosis rate of MG63 induced by CdCl2 25998312
HTSMCs Function Assay 0.1/1/10 μM 1 h inhibited CORM-2-induced HO-1 protein levels and mRNA expression 25921464
MIA PaCa-2 Function Assay 20 μM 24 h reduced lactate accumulation in combination with both 2-DG and D-allose  25888489
MIA PaCa-2 Function Assay 20 μM 24 h results in a modest inhibition of HIF-1α protein accumulation 25888489
BxPC-3 Function Assay 20 μM 24 h results in a modest inhibition of HIF-1α protein accumulation 25888489
AsPC-1 Function Assay 20 μM 24 h results in a modest inhibition of HIF-1α protein accumulation 25888489
MIA PaCa-2 Function Assay 20 μM 24 h enhances cleavage of PARP when combined with glucose analogs 25888489
MIA PaCa-2 Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
BxPC-3 Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
AsPC-1 Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
HEY Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
OVCAR-3 Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
SK-OV-3 Growth Inhibition Assay 20 μM 2 h sensitizes cell lines to treatment with 2-DG and D-allose 25888489
MH7A  Growth Inhibition Assay 24 h reinforces the inhibitory effects of XAN 25862966
MH7A  Apoptosis Assay 25 μM 24 h reverses cell cycle arrest induced by XAN and caused apoptosis of cells via activation of JNK 25862966
SCC25 Function Assay 20 μM 24 h increases autophagy level 25834400
HaCaT  Function Assay 5 µM 24 h inhibits IFN-γ-induced CCL22 production levels 25834353
HaCaT  Function Assay 5 µM 24 h inhibits IFN-α-induced CCL22 production levels 25834353
HPAEpiCs  Function Assay 1/3/10 μM 1 h reduces S1P-induced ICAM-1 protein and mRNA expression and promoter activity 25734900
HPAEpiCs Function Assay 1/3/10 μM 1 h inhibits S1P-stimulated Akt phosphorylation   25734900
HPAEpiCs Function Assay 1/3/10 μM 1 h inhibits S1P time-dependently stimulated c-Jun phosphorylation 25734900
K562 Function Assay 10 μM 1 h DMSO inhibits quinacrine-induced p38 MAPK phosphorylation 25684043
PANC-1 Function Assay 10 μM 1 h enhances the autophagic effect  25632222
BxPC-3 Function Assay 10 μM 1 h enhances the autophagic effect  25632222
K562  Function Assay 0.25-1 μM 24 h suppresses resveratrol-induced H2AX phosphorylation 25619392
THP-1 Function Assay 5 µM 2 h significantly attenuates secretion of IL-1α induced by 27OHChol plus FSL-1  25598661
WB Function Assay 20 μM  30 min decreases the LPS- or LTA-induced IL-6 and TNF-α production 25530682
RAW 264.7 Function Assay 10 μM 30 min induces characteristic vacuolation of OCs  25461399
RAW 264.7 Function Assay 10 μM 30 min attenuates the effects of OPG on osteoclast retraction 25461399
HaCaT  Function Assay 40 μM 3-24 h DMSO reduces the accumulation of ZO-1 25435485
H9c2 Function Assay 50 μM  12 h reduces LDH release and MMP loss 25245818
HSCs Apoptosis Assay 25 μM 24 h significantly attenuates TG-induced activated HSCs apoptosis 24961950
THP-1 Growth Inhibition Assay 72 h DMSO IC50=4.7μM 24815087
MDDCs Growth Inhibition Assay 72 h DMSO IC502.7μM 24815087
MDDCs Function Assay 0-15 μM 48 h DMSO suppresses IFN-α and IP-10 production  24815087
MDDCs Function Assay 0-15 μM 48 h DMSO inhibits MIP-1a, MIP-1b and RANTES production 24815087
MDDCs Function Assay 10 μM 3.5 h DMSO blocks EBOV GP, but not VSV G mediated entry into human MDDCs 24815087
macrophages Function Assay 1 μM 4.5 h completely inhibits MT-III-induced activation of NF-κB 24808633
PDL  Function Assay 20 μM  30 min DMSO significantly inhibits the tensile force-mediated BMP-2 expression 24561081
AGS Function Assay 5 μM 30 min suppresses 1-induced caspase-8 and caspase-3 activation 24547878
H520 Function Assay 10 µM 1 h DMSO decreases the pemetrexed-induced MSH2 mRNA and protein levels 24530475
H1703 Function Assay 10 µM 1 h DMSO decreases the pemetrexed-induced MSH2 mRNA and protein levels 24530475
H520 Function Assay 10 µM 12 h DMSO inhibits pemetrexed-elicited MSH2 protein stability 24530475
H1703 Function Assay 10 µM 12 h DMSO inhibits pemetrexed-elicited MSH2 protein stability 24530475
H520 Function Assay 10 µM 6 h DMSO significantly increases the levels of ubiquitin-conjugated MSH2 in pemetrexed-treated cell line 24530475
H1703 Function Assay 10 µM 6 h DMSO significantly increases the levels of ubiquitin-conjugated MSH2 in pemetrexed-treated cell line 24530475
MC3T3-E1 Function Assay 0.3/3/30 μM 1 h attenuates TNF-α-induced MMP-9 expression in a concentration-dependent manner  24502696
MC3T3-E1 Function Assay 30 μM 1 h attenuates TNF-α-stimulated p38 MAPK phosphorylation 24502696
HUVECs  Function Assay 10 µM 1 h inhibits TNF-α-induced CXCL1 production 24487964
AGS  Function Assay 10 µM 30 min inhibits IL-1β-induced activation of p38 24479681
MKN-45 Function Assay 10 µM 30 min inhibits IL-1β-induced activation of p38 24479681
AGS  Function Assay 10 µM 30 min attenuates IL-1β-induced GA cell migration and invasion 24479681
MKN-45 Function Assay 10 µM 30 min attenuates IL-1β-induced GA cell migration and invasion 24479681
AGS  Function Assay 10 µM 30 min significantly decreases Il-1β-induced MMP2 and MMP9 mRNA expression 24479681
MKN-45 Function Assay 10 µM 30 min significantly decreases Il-1β-induced MMP2 and MMP9 mRNA expression 24479681
DCs Function Assay 20 μM 1 h decreases IL-12 production 24434636
HUVEC  Function Assay 20 μm  5 h DMSO reduces cytokine expression levels in a concentration-dependent manner 24189062
A 549 Function Assay 50 μM 1 h decreases the level of IL-8  24179688
H520  Function Assay 5/10 μM 1 h DMSO decreases MSH2 protein as well as mRNA levels in gefitinib-exposed cell 24138903
H1703  Function Assay 5/10 μM 1 h DMSO decreases MSH2 protein as well as mRNA levels in gefitinib-exposed cell 24138903
H520  Function Assay 10 µM 12 h DMSO decreases MSH2 mRNA and protein stability in gefitinib-treated NSCLC cells 24138903
H1703  Function Assay 10 µM 12 h DMSO decreases MSH2 mRNA and protein stability in gefitinib-treated NSCLC cells 24138903
MCF-7  Growth Inhibition Assay 10 μM 24 h inhibits the CR108-induced cell death 24128853
HPAEpiCs Function Assay 0.1/1/10 μM 1 h inhibits TNF-α-induced cPLA2 protein and mRNA expression 24069158
podocytes Function Assay 10 μM 1 h inhibits TGFβ1-induced activation of p38MAPK and Erk1/2  24036212
MCF-7 Function Assay 10 μM 1 h DMSO reduces the WA-induced phosphorylated p38 MAPK 24019090
MCF-7 Function Assay 10 μM 24 h DMSO increases the WA-induced apoptosis 24019090
HAPI Function Assay 10/20/40 μM 1 h inhibits TCDD-induced p38/JNK MAPK phosphorylation 23969120
HAPI Function Assay 20 μM  1 h DMSO attenuates TCDD-induced activation of iNOS and production 23969120
HepG2 Function Assay 350 nM 24 h inhibits the deguelin-induced activation of p38MAPK 23933198
AGS  Function Assay 10 μM 30 min inhibits caspase-3 activation and inhibition of ERK 23850994
HepG2 Growth Inhibition Assay 0-50 μM 48 h inhibits the proliferation in a dose dependent manner 23807508
BEL7404 Growth Inhibition Assay 0-50 μM 48 h inhibits the proliferation in a dose dependent manner 23807508
HL7702 Growth Inhibition Assay 0-50 μM 48 h inhibits the proliferation in a dose dependent manner 23807508
HepG2 Function Assay 0-50 μM 24 h inhibits the phosphorylation of p38 downstream proteins MAPKAPK2, ATF2, MSK1 and HSP27 in a dose-dependent manner 23807508
BEAS-2B Growth Inhibition Assay 10 μM 30 min reverses the decrease of cell viability induced by HCI 23784034
BEAS-2B Cytotoxity Assay 10 μM 30 min inhibited the increase in LDH and IL-8 expression 23784034
BEAS-2B Function Assay 10 μM 30 min decreases the levels of caspase-3, Bad and fas 23784034
H9c2  Function Assay 0.01/0.1/1 μM 1 h attenuates TNF-α-induced MMP-9 expression, mRNA levels, and promoter activity 23774252
H9c2  Function Assay 1 μM 1 h reduces TNF-α directly stimulated p38 MAPK phosphorylation 23774252
U937 Function Assay 10 μM  1 h abrogates the caffeine effect on MKP-1 and PP2Acα mRNA transcriptional levels 23707387
U937 Function Assay 10 μM  1 h abrogates caffeine-induced MKP-1 down-regulation and PP2Acα up-regulation 23707387
U937 Function Assay 10 μM  1 h suppresses c-Jun and CREB phosphorylation in caffeine-treated cells  23707387
A549 Function Assay 0.3/3/30 μM 1 h significantly attenuates ATPγS-mediated COX-2 protein and mRNA expression and promoter activity  23680674
A549 Function Assay 10 μM  0-30 min inhibits ATPγS induced p42/p44 MAPK and p38 MAPK phosphorylation 23680674
A549 Function Assay 10 μM  1 h inhibits ATPγS induced NF-κB p65 subunit phosphorylation and NF-κB promoter activity 23680674
A549 Function Assay 10 μM  1 h reduces ATPγS-stimulated cPLA2 phosphorylation  23680674
A549 Function Assay 10 μM  1 h reduces ATPγS-enhanced enzymatic activity of cPLA2  23680674
PC12 Function Assay 10/20/40 μM 1 h inhibits JNK and p38 23584357
HK-2 Apoptosis Assay 20 μM 24 h inhibits ERK and p38MAPK 23543151
H9c2 Function Assay 1 μM 1 h reduces TNF-α-induced MMP-9 mRNA levels and promoter activity 23353699
H9c2 Function Assay 1 μM 1 h reduces TNF-α-enhanced AP-1 promoter activity 23353699
H1650  Function Assay 10 μM  1 h DMSO decreases both protein and mRNA levels of ERCC1 in paclitaxel-exposed cells 23228696
H1703 Function Assay 10 μM  1 h DMSO decreases both protein and mRNA levels of ERCC1 in paclitaxel-exposed cells 23228696
H1650  Growth Inhibition Assay 10 μM  1 h DMSO enhances paclitaxel-induced cytotoxicity 23228696
H1703 Growth Inhibition Assay 10 μM  1 h DMSO enhances paclitaxel-induced cytotoxicity 23228696

... Click to View More Cell Line Experimental Data

In vivo Inhibiting p38 by administration of SB 202190 inhibits PV IgG-induced blister formation in the passive transfer mouse model. [5] In the endotoxin model of sepsis, SB 202190 treatment produces a statistically significant survival benefit compared with control. [8]